Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anne-Lise, Kamper"'
Autor:
Nicholas Carlson, Kristine Hommel, Jonas Bjerring Olesen, Anne-Merete Soja, Tina Vilsbøll, Anne-Lise Kamper, Christian Torp-Pedersen, Gunnar Gislason
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159944 (2016)
Dialysis-requiring acute kidney injury (AKI) is associated with substantial mortality and risk of end-stage renal disease (ESRD). Despite considerable growth in incidence of severe AKI, information pertaining to trends in outcomes remains limited. We
Externí odkaz:
https://doaj.org/article/9594919681d7463d9a7ff7b017985c8e
Autor:
Nicholas Carlson, Kristine Hommel, Jonas Bjerring Olesen, Anne-Merete Soja, Tina Vilsbøll, Anne-Lise Kamper, Christian Torp-Pedersen, Gunnar Gislason
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148809 (2016)
INTRODUCTION:Dialysis-requiring acute kidney injury is a severe illness associated with poor prognosis. However, information pertaining to incidence rates and prevalence of risk factors remains limited in spite of increasing focus. We evaluate time t
Externí odkaz:
https://doaj.org/article/28c96b951b9e46bba2bf1bda5c827923
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64549 (2013)
Patients with chronic kidney disease (CKD) have high cardiovascular mortality and morbidity associated with increased arterial stiffness. Plasma aldosterone levels are increased in CKD, and aldosterone has been found to increase vascular inflammation
Externí odkaz:
https://doaj.org/article/4b256ac615e14e3889bd48ea0bca0810
Autor:
Dhivya Thiyagarajan, Silje Fismen, Natalya Seredkina, Søren Jacobsen, Thomas Elung-Jensen, Anne-Lise Kamper, Christopher Graham Fenton, Ole Petter Rekvig, Elin Synnøve Mortensen
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34080 (2012)
Recent studies demonstrate that transformation of mild lupus nephritis into end-stage disease is imposed by silencing of renal DNaseI gene expression in (NZBxNZW)F1 mice. Down-regulation of DNaseI results in reduced chromatin fragmentation, and in de
Externí odkaz:
https://doaj.org/article/c26c61e448d443bc8c418af79aa4a0f8
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41757 (2012)
Cardiovascular disease (CVD) is highly prevalent in patients with chronic kidney disease (CKD). Inhibition of the renin-angiotensinsystem (RAS) in hypertension causes differential effects on central and brachial blood pressure (BP), which has been tr
Externí odkaz:
https://doaj.org/article/108c140184c043018851979ca2a92e12
Autor:
Lene Boesby, Thomas Elung-Jensen, Tobias Wirenfeldt Klausen, Svend Strandgaard, Anne-Lise Kamper
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26904 (2011)
Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its use is limi
Externí odkaz:
https://doaj.org/article/c395607d14dc4ecda3b8d33d79a4a945
Autor:
Christian Torp-Pedersen, Nicholas Carlson, Anne-Lise Kamper, Kristine Hommel, Tina Vilsbøll, Anne Merete Boas Soja, Jonas Bjerring Olesen, Gunnar Gislason
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148809 (2016)
PLoS ONE
PLoS ONE
Introduction Dialysis-requiring acute kidney injury is a severe illness associated with poor prognosis. However, information pertaining to incidence rates and prevalence of risk factors remains limited in spite of increasing focus. We evaluate time t
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41757 (2012)
PLoS ONE
PLoS ONE
Background: Cardiovascular disease (CVD) is highly prevalent in patients with chronic kidney disease (CKD). Inhibition of the renin-angiotensinsystem (RAS) in hypertension causes differential effects on central and brachial blood pressure (BP), which
Autor:
Svend Strandgaard, Anne-Lise Kamper, Lene Boesby, Thomas Elung-Jensen, Tobias Wirenfeldt Klausen
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26904 (2011)
PLoS ONE
PLoS ONE
Background Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its
Autor:
Natalya Seredkina, Christopher Graham Fenton, Elin Synnøve Mortensen, Silje Fismen, Thomas Elung-Jensen, Ole Petter Rekvig, Anne-Lise Kamper, Dhivya Thiyagarajan, Søren Jacobsen
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34080 (2012)
PLoS ONE
PLoS ONE
This paper is part of Dhivya Thiyagarajan's doctoral thesis, available in Munin at http://hdl.handle.net/10037/5484 Recent studies demonstrate that transformation of mild lupus nephritis into end-stage disease is imposed by silencing of renal DNaseI